Celsius Holdings

CELH · NASDAQ

$29.96+$0.24 (+0.81%)TodayMarket closed ·
Prev close $29.72

CELH analyst rating

BuyConsensus of 17 analysts over the last 12 months. 76% rate it a buy.
  • Strong buy0
  • Buy13
  • Hold4
  • Underperform0
  • Sell0

12-month price target · 24 analysts

Average $42.68 (+42.4% upside)

Low
$26.26
Now
$29.96
High
$67.20

Upgrades and downgrades

The latest rating actions, newest first

CELH analyst upgrades, downgrades and rating actions
FirmDateActionRating
TD CowenOct 13, 2026MaintainsBuy
Stephens & Co.Aug 10, 2026MaintainsOverweight
Maxim GroupAug 7, 2026DowngradeBuy → Hold
UBSAug 7, 2026MaintainsBuy
CitigroupAug 7, 2026MaintainsBuy
Morgan StanleyAug 7, 2026MaintainsOverweight
JP MorganAug 7, 2026MaintainsOverweight
BernsteinAug 7, 2026DowngradeOutperform → Market Perform
Piper SandlerAug 7, 2026MaintainsOverweight
NeedhamAug 6, 2026MaintainsBuy

The case for and against

Updated Oct 18, 2026

Bull case

Celsius Holdings is supported by a structurally attractive energy drink category, with double-digit volume growth YTD, a rising female consumer base, and a shift toward zero sugar products that should help its core Celsius and Alani Nu brands sustain share gains. Despite 2Q26 net sales of $817.9 million rising 10.6% y/y, the company’s core brand fell 11.7% because of inventory rebalancing and contra revenue, while Alani Nu grew 21.0% and surpassed $1 billion of tracked retail sales in 1H26, showing portfolio resilience. With PepsiCo’s distribution support, international growth already in North America-heavy operations, and expectations for double-digit adjusted EBITDA growth alongside a high-single-digit free cash flow yield, the stock appears fundamentally compelling even after the recent reset.

Bear case

Celsius Holdings is facing a weak fundamental setup because its growth remains heavily dependent on a highly competitive energy drink market, where larger rivals can pressure pricing, shelf space, and consumer loyalty while Celsius relies on outsourced co-packers and PepsiCo’s distribution network. Recent results already show the strain: revenue of $818 mm missed consensus by 6%, core Celsius declined 12%, and Alani Nu’s $365M in 2Q26 net sales was offset by about $63M of incremental DSD costs and up to a 15% gross-sales headwind. With 95% of revenue in North America, elevated A&P spend, margin pressure from volume deleverage, and no near-term catalyst to offset execution risk, the stock’s fundamentals look increasingly fragile.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.